![Danny Robert Hegglin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Danny Robert Hegglin
Keine laufenden Positionen mehr
Profil
Danny Robert Hegglin served as a Non-Executive Director at Realm Therapeutics Plc from 2013 to 2017 and as a Partner at TT International (Hong Kong) Ltd.
from 2009 to 2013.
Ehemalige bekannte Positionen von Danny Robert Hegglin
Unternehmen | Position | Ende |
---|---|---|
REALM THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 17.11.2017 |
TT International (Hong Kong) Ltd.
![]() TT International (Hong Kong) Ltd. Investment ManagersFinance TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors. | Präsident | 01.01.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
TT International (Hong Kong) Ltd.
![]() TT International (Hong Kong) Ltd. Investment ManagersFinance TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors. | Finance |
Realm Therapeutics Plc
![]() Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |